• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

N-乙酰半胱氨酸的抗炎功效及治疗用途

[Anti-inflammatory efficacy of N-acetylcysteine and therapeutic usefulness].

作者信息

Gillissen A

机构信息

Klinik für Lungen- und Bronchialmedizin, Klinikum Kassel.

出版信息

Pneumologie. 2011 Sep;65(9):549-57. doi: 10.1055/s-0030-1256592. Epub 2011 Jul 14.

DOI:10.1055/s-0030-1256592
PMID:21761386
Abstract

N-acetylcyteine (NAC) is a thiol containing compound which by providing Sulfhydryl groups, can act both as a precursor or reduced glutathione and as a direct scavenger of reactive oxygen species. By regulation the redox status in cells, it can interfere with several signaling pathways that play a role in regulation apoptosis, angiogenesis, cell growth, nuclear transcription and cytokine production. In humans NAC had been proven to improve idiopathic pulmonary fibrosis (IPF), various forms of alveolitis and to avoid hepatoxic effects of paracetamol and paraquate through binding these compounds enabling biliary excretion. Overall, the anti-inflammatory action of NAC is well documented in vitro as well as in vivo. This review summarizes the biochemical effects of NAC and hints proven and likely diseases where NAC have or might have a beneficial effect.

摘要

N-乙酰半胱氨酸(NAC)是一种含硫醇的化合物,它通过提供巯基,既可以作为还原型谷胱甘肽的前体,又可以作为活性氧的直接清除剂。通过调节细胞内的氧化还原状态,它可以干扰多种在细胞凋亡、血管生成、细胞生长、核转录和细胞因子产生的调节中起作用的信号通路。在人类中,已证实NAC可改善特发性肺纤维化(IPF)、各种形式的肺泡炎,并通过结合对乙酰氨基酚和百草枯使其经胆汁排泄,从而避免其肝毒性作用。总体而言,NAC的抗炎作用在体外和体内均有充分记录。本综述总结了NAC的生化作用,并提示了已证实的以及可能对NAC有有益作用的疾病。

相似文献

1
[Anti-inflammatory efficacy of N-acetylcysteine and therapeutic usefulness].N-乙酰半胱氨酸的抗炎功效及治疗用途
Pneumologie. 2011 Sep;65(9):549-57. doi: 10.1055/s-0030-1256592. Epub 2011 Jul 14.
2
N-Acetylcysteine mucolysis in the management of chronic obstructive pulmonary disease.N-乙酰半胱氨酸在慢性阻塞性肺疾病治疗中的黏液溶解作用。
Ther Adv Respir Dis. 2012 Jun;6(3):127-35. doi: 10.1177/1753465812437563. Epub 2012 Feb 23.
3
Antioxidant and anti-inflammatory efficacy of NAC in the treatment of COPD: discordant in vitro and in vivo dose-effects: a review.N-乙酰半胱氨酸治疗慢性阻塞性肺疾病的抗氧化和抗炎疗效:体外和体内剂量效应不一致:综述
Pulm Pharmacol Ther. 2007;20(1):9-22. doi: 10.1016/j.pupt.2005.12.007. Epub 2006 Feb 3.
4
[Antioxidant treatment with N-acetylcysteine and vitamin C in patients with chronic bronchitis].
Dtsch Med Wochenschr. 2005 Mar 18;130(11):563-7. doi: 10.1055/s-2005-865062.
5
[N-acetylcysteine: a functional oxygen radical scavenger in vitro and ex vivo in monocytes and neutrophilic granulocytes of patients with COPD].[N-乙酰半胱氨酸:慢性阻塞性肺疾病患者单核细胞和中性粒细胞体外及体内的功能性氧自由基清除剂]
Pneumologie. 1995 Oct;49(10):539-45.
6
[Therapeutic use of N-acetylcysteine in acute lung diseases].
Rev Mal Respir. 1999 Feb;16(1):29-37.
7
Characterization of N-acetylcysteine and ambroxol in anti-oxidant therapy.抗氧化治疗中N-乙酰半胱氨酸和氨溴索的特性
Respir Med. 1998 Apr;92(4):609-23. doi: 10.1016/s0954-6111(98)90506-6.
8
Lead induced oxidative stress and its recovery following co-administration of melatonin or N-acetylcysteine during chelation with succimer in male rats.在雄性大鼠与二巯基丁二酸螯合期间,同时给予褪黑素或N-乙酰半胱氨酸后铅诱导的氧化应激及其恢复情况。
Cell Mol Biol (Noisy-le-grand). 2004;50 Online Pub:OL543-51.
9
Clinical applications of N-acetylcysteine.N-乙酰半胱氨酸的临床应用
Altern Med Rev. 1998 Apr;3(2):114-27.
10
[Acetylcysteine in chronic obstructive pulmonary disease. Secretolytic, antioxidant or placebo?].[慢性阻塞性肺疾病中的乙酰半胱氨酸。黏液溶解剂、抗氧化剂还是安慰剂?]
Med Monatsschr Pharm. 2003 Nov;26(11):375-8.

引用本文的文献

1
Effect of Antioxidants in the Treatment of COPD Patients: Scoping Review.抗氧化剂在慢性阻塞性肺疾病患者治疗中的作用:范围综述
J Nutr Metab. 2021 Nov 24;2021:7463391. doi: 10.1155/2021/7463391. eCollection 2021.
2
Re-administration of gefitinib following diffuse interstitial lung disease in a patient with advanced lung adenocarcinoma: A case report and review of the literature.晚期肺腺癌患者弥漫性间质性肺病后再次给予吉非替尼治疗:一例病例报告及文献复习
Oncol Lett. 2015 May;9(5):2419-2421. doi: 10.3892/ol.2015.3026. Epub 2015 Mar 11.